| Literature DB >> 33692757 |
Carmel Braverman-Gross1, Nissim Benvenisty1.
Abstract
Maturity onset diabetes of the young (MODY), is a group of monogenic diabetes disorders. Rodent models for MODY do not fully recapitulate the human phenotypes, calling for models generated in human cells. Human pluripotent stem cells (hPSCs), capable of differentiation towards pancreatic cells, possess a great opportunity to model MODY disorders in vitro. Here, we review the models for MODY diseases in hPSCs to date and the molecular lessons learnt from them. We also discuss the limitations and challenges that these types of models are still facing.Entities:
Keywords: disease modeling; genetic and epigenetic aberrations; human embryonic stem cells; induced pluripotent stem cells; maturity onset diabetes of the young
Mesh:
Year: 2021 PMID: 33692757 PMCID: PMC7937923 DOI: 10.3389/fendo.2021.622940
Source DB: PubMed Journal: Front Endocrinol (Lausanne) ISSN: 1664-2392 Impact factor: 5.555